Department of Respiratory and Critical Care Medicine, Peking University Third Hospital, Beijing, 100191, People's Republic of China.
Department of Respiratory and Critical Care Medicine, Tibet Autonomous Region People's Hospital, Lhasa, 850000, People's Republic of China.
Int J Chron Obstruct Pulmon Dis. 2023 May 12;18:849-858. doi: 10.2147/COPD.S397996. eCollection 2023.
COPD patients living in Tibet are exposed to specific environments and different risk factors and probably have different characteristics of COPD from those living in flatlands. We aimed to describe the distinction between stable COPD patients permanently residing at the Tibet plateau and those in flatlands.
We conducted an observational cross-sectional study that enrolled stable COPD patients from Tibet Autonomous Region People's Hospital (Plateau Group) and Peking University Third Hospital (Flatland Group), respectively. Their demographic information, clinical features, spirometry test, blood routine and high-resolution chest CT were collected and evaluated.
A total of 182 stable COPD patients (82 from plateau and 100 from flatland) were consecutively enrolled. Compared to those in flatlands, patients in plateau had a higher proportion of females, more biomass fuel use and less tobacco exposure. CAT score and frequency of exacerbation in the past year were higher in plateau patients. The blood eosinophil count was lower in plateau patients, with fewer patients having an eosinophil count ≥300/μL. On CT examination, the proportions of previous pulmonary tuberculosis and bronchiectasis were higher in plateau patients, but emphysema was less common and milder. The ratio of diameters of pulmonary artery to aorta ≥1 was more often in plateau patients.
Patients with COPD living at Tibet Plateau had a heavier respiratory burden, lower blood eosinophil count, less emphysema but more bronchiectasis and pulmonary hypertension. Biomass exposure and previous tuberculosis were more common in these patients.
生活在西藏的 COPD 患者面临着特殊的环境和不同的危险因素,其 COPD 特征可能与平原地区的患者不同。本研究旨在描述长期居住在高原地区的 COPD 稳定期患者与平原地区患者的区别。
我们进行了一项观察性的横断面研究,分别从西藏自治区人民医院(高原组)和北京大学第三医院(平原组)招募稳定期 COPD 患者。收集并评估了他们的人口统计学信息、临床特征、肺功能检查、血常规和高分辨率胸部 CT。
共纳入了 182 名稳定期 COPD 患者(高原组 82 名,平原组 100 名)。与平原地区患者相比,高原地区患者女性比例更高,更多使用生物质燃料,较少吸烟。高原地区患者的 CAT 评分和过去一年的急性加重频率更高。高原地区患者的血嗜酸性粒细胞计数较低,血嗜酸性粒细胞计数≥300/μL 的患者比例较少。在 CT 检查中,高原地区患者既往肺结核和支气管扩张的比例较高,但肺气肿较少且较轻。肺动脉直径与主动脉直径比≥1 的患者比例在高原地区更高。
生活在西藏高原的 COPD 患者呼吸负担更重,血嗜酸性粒细胞计数较低,肺气肿较少,但支气管扩张和肺动脉高压更为常见。这些患者更常暴露于生物质燃料和既往患有肺结核。